Say Hello to Aimovig™!

Say Hello to Aimovig™!

It’s a great day for sufferers of Episodic and Chronic Migraine! The first of the new class of CGRP antibodiesthe only drug specifically designed to prevent migraine—was approved by the FDA on May 17, 2018 and is available NOW for patients at The Headache Center.

The Headache Center is currently the only provider in the state of Mississippi offering this groundbreaking treatment, and we have partnered with the Aimovig Ally program to ensure the treatment is affordable and accessible.


This drug is approved for the treatment of all types of Migraine. Whether you suffer from chronic or episodic Migraine, with aura or without, you may be eligible for treatment with Aimovig™.
We will be providing many more educational resources about Aimovig™ and CGRP-related treatment in the coming days and weeks, so make sure you’re in the loop by keeping an eye on our Blog and using the form on the right side of this page to subscribe to our Newsletter.

additional resources

Close Menu